TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: The roles of extracellular SOD and NADPH oxidase

Tadaaki Nakashima, Seiji Umemoto, Koichi Yoshimura, Susumu Matsuda, Shinichi Itoh, Tomoaki Murata, Tohru Fukai, Masunori Matsuzaki

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Toll-like receptor 4 (TLR4) and angiotensin II (AngII) induce vascular remodeling through the production of reactive oxygen species (ROS). AngII has also been shown to increase antioxidant enzyme extracellular superoxide dismutase (ecSOD). However, the roles of TLR4 in Ang II-induced ROS production, vascular remodeling and hypertension remain unknown. Mice lacking TLR4 function showed significant inhibition of vascular remodeling in response to chronic AngII infusion, with no impact on blood pressure. The increases in ROS level and NADPH oxidase activity in response to AngII infusion were markedly blunted in TLR4-deficient mice. Similar effects were observed in wild-type (WT) mice treated with a sub-depressor dose of the AT1 receptor antagonist irbesartan, which had no effects on TLR4-deficient mice. Intriguingly, the AngII infusion-induced increases in ecSOD activity and expression were rather enhanced in TLR4-deficient mice compared with WT mice, whereas the expression of the proinflammatory chemokine MCP-1 was decreased. Importantly, AngII-induced vascular remodeling was positively correlated with NADPH oxidase activity, ROS levels and MCP-1 expression levels. Notably, chronic norepinephrine infusion, which elevates blood pressure without increasing ROS production, did not induce significant vascular remodeling in WT mice. Taken together, these findings suggest that ROS elevation is required for accelerating vascular remodeling but not for hypertensive effects in this model. We demonstrated that TLR4 plays a pivotal role in regulating AngII-induced vascular ROS levels by inhibiting the expression and activity of the antioxidant enzyme ecSOD, as well as by activating NADPH oxidase, which enhances inflammation to facilitate the progression of vascular remodeling.

Original languageEnglish (US)
Pages (from-to)649-655
Number of pages7
JournalHypertension Research
Volume38
Issue number10
DOIs
StatePublished - Oct 1 2015

Fingerprint

Toll-Like Receptor 4
NADPH Oxidase
Angiotensin II
Reactive Oxygen Species
Superoxide Dismutase
irbesartan
Antioxidants
Blood Pressure
Enzymes
Vascular Remodeling
Chemokines
Blood Vessels
Norepinephrine
Hypertension
Inflammation
Mouse Tlr4 protein

Keywords

  • Toll-like receptor 4
  • angiotensin II
  • extracellular superoxide dismutase
  • vascular remodeling

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Nakashima, T., Umemoto, S., Yoshimura, K., Matsuda, S., Itoh, S., Murata, T., ... Matsuzaki, M. (2015). TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: The roles of extracellular SOD and NADPH oxidase. Hypertension Research, 38(10), 649-655. https://doi.org/10.1038/hr.2015.55

TLR4 is a critical regulator of angiotensin II-induced vascular remodeling : The roles of extracellular SOD and NADPH oxidase. / Nakashima, Tadaaki; Umemoto, Seiji; Yoshimura, Koichi; Matsuda, Susumu; Itoh, Shinichi; Murata, Tomoaki; Fukai, Tohru; Matsuzaki, Masunori.

In: Hypertension Research, Vol. 38, No. 10, 01.10.2015, p. 649-655.

Research output: Contribution to journalArticle

Nakashima, T, Umemoto, S, Yoshimura, K, Matsuda, S, Itoh, S, Murata, T, Fukai, T & Matsuzaki, M 2015, 'TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: The roles of extracellular SOD and NADPH oxidase', Hypertension Research, vol. 38, no. 10, pp. 649-655. https://doi.org/10.1038/hr.2015.55
Nakashima, Tadaaki ; Umemoto, Seiji ; Yoshimura, Koichi ; Matsuda, Susumu ; Itoh, Shinichi ; Murata, Tomoaki ; Fukai, Tohru ; Matsuzaki, Masunori. / TLR4 is a critical regulator of angiotensin II-induced vascular remodeling : The roles of extracellular SOD and NADPH oxidase. In: Hypertension Research. 2015 ; Vol. 38, No. 10. pp. 649-655.
@article{94a9f0b8144b471082f1dc6a1a9315dd,
title = "TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: The roles of extracellular SOD and NADPH oxidase",
abstract = "Toll-like receptor 4 (TLR4) and angiotensin II (AngII) induce vascular remodeling through the production of reactive oxygen species (ROS). AngII has also been shown to increase antioxidant enzyme extracellular superoxide dismutase (ecSOD). However, the roles of TLR4 in Ang II-induced ROS production, vascular remodeling and hypertension remain unknown. Mice lacking TLR4 function showed significant inhibition of vascular remodeling in response to chronic AngII infusion, with no impact on blood pressure. The increases in ROS level and NADPH oxidase activity in response to AngII infusion were markedly blunted in TLR4-deficient mice. Similar effects were observed in wild-type (WT) mice treated with a sub-depressor dose of the AT1 receptor antagonist irbesartan, which had no effects on TLR4-deficient mice. Intriguingly, the AngII infusion-induced increases in ecSOD activity and expression were rather enhanced in TLR4-deficient mice compared with WT mice, whereas the expression of the proinflammatory chemokine MCP-1 was decreased. Importantly, AngII-induced vascular remodeling was positively correlated with NADPH oxidase activity, ROS levels and MCP-1 expression levels. Notably, chronic norepinephrine infusion, which elevates blood pressure without increasing ROS production, did not induce significant vascular remodeling in WT mice. Taken together, these findings suggest that ROS elevation is required for accelerating vascular remodeling but not for hypertensive effects in this model. We demonstrated that TLR4 plays a pivotal role in regulating AngII-induced vascular ROS levels by inhibiting the expression and activity of the antioxidant enzyme ecSOD, as well as by activating NADPH oxidase, which enhances inflammation to facilitate the progression of vascular remodeling.",
keywords = "Toll-like receptor 4, angiotensin II, extracellular superoxide dismutase, vascular remodeling",
author = "Tadaaki Nakashima and Seiji Umemoto and Koichi Yoshimura and Susumu Matsuda and Shinichi Itoh and Tomoaki Murata and Tohru Fukai and Masunori Matsuzaki",
year = "2015",
month = "10",
day = "1",
doi = "10.1038/hr.2015.55",
language = "English (US)",
volume = "38",
pages = "649--655",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - TLR4 is a critical regulator of angiotensin II-induced vascular remodeling

T2 - The roles of extracellular SOD and NADPH oxidase

AU - Nakashima, Tadaaki

AU - Umemoto, Seiji

AU - Yoshimura, Koichi

AU - Matsuda, Susumu

AU - Itoh, Shinichi

AU - Murata, Tomoaki

AU - Fukai, Tohru

AU - Matsuzaki, Masunori

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Toll-like receptor 4 (TLR4) and angiotensin II (AngII) induce vascular remodeling through the production of reactive oxygen species (ROS). AngII has also been shown to increase antioxidant enzyme extracellular superoxide dismutase (ecSOD). However, the roles of TLR4 in Ang II-induced ROS production, vascular remodeling and hypertension remain unknown. Mice lacking TLR4 function showed significant inhibition of vascular remodeling in response to chronic AngII infusion, with no impact on blood pressure. The increases in ROS level and NADPH oxidase activity in response to AngII infusion were markedly blunted in TLR4-deficient mice. Similar effects were observed in wild-type (WT) mice treated with a sub-depressor dose of the AT1 receptor antagonist irbesartan, which had no effects on TLR4-deficient mice. Intriguingly, the AngII infusion-induced increases in ecSOD activity and expression were rather enhanced in TLR4-deficient mice compared with WT mice, whereas the expression of the proinflammatory chemokine MCP-1 was decreased. Importantly, AngII-induced vascular remodeling was positively correlated with NADPH oxidase activity, ROS levels and MCP-1 expression levels. Notably, chronic norepinephrine infusion, which elevates blood pressure without increasing ROS production, did not induce significant vascular remodeling in WT mice. Taken together, these findings suggest that ROS elevation is required for accelerating vascular remodeling but not for hypertensive effects in this model. We demonstrated that TLR4 plays a pivotal role in regulating AngII-induced vascular ROS levels by inhibiting the expression and activity of the antioxidant enzyme ecSOD, as well as by activating NADPH oxidase, which enhances inflammation to facilitate the progression of vascular remodeling.

AB - Toll-like receptor 4 (TLR4) and angiotensin II (AngII) induce vascular remodeling through the production of reactive oxygen species (ROS). AngII has also been shown to increase antioxidant enzyme extracellular superoxide dismutase (ecSOD). However, the roles of TLR4 in Ang II-induced ROS production, vascular remodeling and hypertension remain unknown. Mice lacking TLR4 function showed significant inhibition of vascular remodeling in response to chronic AngII infusion, with no impact on blood pressure. The increases in ROS level and NADPH oxidase activity in response to AngII infusion were markedly blunted in TLR4-deficient mice. Similar effects were observed in wild-type (WT) mice treated with a sub-depressor dose of the AT1 receptor antagonist irbesartan, which had no effects on TLR4-deficient mice. Intriguingly, the AngII infusion-induced increases in ecSOD activity and expression were rather enhanced in TLR4-deficient mice compared with WT mice, whereas the expression of the proinflammatory chemokine MCP-1 was decreased. Importantly, AngII-induced vascular remodeling was positively correlated with NADPH oxidase activity, ROS levels and MCP-1 expression levels. Notably, chronic norepinephrine infusion, which elevates blood pressure without increasing ROS production, did not induce significant vascular remodeling in WT mice. Taken together, these findings suggest that ROS elevation is required for accelerating vascular remodeling but not for hypertensive effects in this model. We demonstrated that TLR4 plays a pivotal role in regulating AngII-induced vascular ROS levels by inhibiting the expression and activity of the antioxidant enzyme ecSOD, as well as by activating NADPH oxidase, which enhances inflammation to facilitate the progression of vascular remodeling.

KW - Toll-like receptor 4

KW - angiotensin II

KW - extracellular superoxide dismutase

KW - vascular remodeling

UR - http://www.scopus.com/inward/record.url?scp=84943176475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943176475&partnerID=8YFLogxK

U2 - 10.1038/hr.2015.55

DO - 10.1038/hr.2015.55

M3 - Article

C2 - 25854990

AN - SCOPUS:84943176475

VL - 38

SP - 649

EP - 655

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 10

ER -